Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)

PHASE4CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 15, 2018

Study Completion Date

October 15, 2018

Conditions
Heart Failure
Interventions
DRUG

ivabradine

Active Comparator: ivabradine

OTHER

Usual Care

Placebo Comparator: usual care

Trial Locations (20)

10467

Montefiore Medical Center, The Bronx

11215

New York Methodist Hospital, Brooklyn

23507

Sentara Norfolk General Hospital, Norfolk

27705

Duke University, Durham

30117

Tanner Medical Center, Carrollton

30606

Athens Regional Medical Center, Athens

30901

University Hospital, Augusta

33308

Holy Cross Hospital, Fort Lauderdale

38138

Stern Cardiovascular Foundation, Germantown

43210

Ohio State University- Davis Heart and Lung Research Institute, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

46260

Saint Vincent Medical Group, Inc., Indianapolis

46514

Midwest Cardiovascular Research, Elkhart

49707

Great Lakes Heart Center of Alpena, Alpena

54601

Gundersen Lutheran Medical Center, La Crosse

63110

Washington University School of Medicine, St Louis

75226

Baylor University Medical Center, Dallas

79912

William Beaumont Army Medical Center, El Paso

80045

University of Colorado at Denver and Health Sciences Center, Aurora

10029-6574

Mount Sinai Medical Center, New York

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Duke University

OTHER